A phase II trial of cardioprotection with Cardioxane (ICRF-187) in patients with advanced breast cancer receiving 5-fluorouracil, doxorubicin and cyclophosphamide (Q42278640)
Jump to navigation
Jump to search
scientific article published on May 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II trial of cardioprotection with Cardioxane (ICRF-187) in patients with advanced breast cancer receiving 5-fluorouracil, doxorubicin and cyclophosphamide |
scientific article published on May 1995 |
Statements
1 reference
A phase II trial of cardioprotection with Cardioxane (ICRF-187) in patients with advanced breast cancer receiving 5-fluorouracil, doxorubicin and cyclophosphamide (English)
1 reference
Kolaric K
1 reference
Bradamante V
1 reference
Cervek J
1 reference
Cieslinska A
1 reference
Cisarz-Filipcak E
1 reference
Denisov LE
1 reference
Donat D
1 reference
Drosik K
1 reference
Gershanovic M
1 reference
Hudziec P
1 reference
1 May 1995
1 reference
1 reference
52
1 reference
3
1 reference
251-255
1 reference
Identifiers
1 reference